[Skip to Navigation]
Sign In

Year

Day

January 13, 2022
Original Investigation

Evaluation of Artificial Intelligence–Based Intraoperative Guidance Tools for Phacoemulsification Cataract Surgery

Abstract Full Text
has multimedia
JAMA Ophthalmol. Published online January 13, 2022. doi:10.1001/jamaophthalmol.2021.5742

This cross-sectional study of patients undergoing phacoemulsification cataract surgery assesses whether use of a deep learning detection network and computer vision tools can provide real-time surgical guidance.

Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials

Abstract Full Text
JAMA Ophthalmol. Published online January 13, 2022. doi:10.1001/jamaophthalmol.2021.5765

This post hoc analysis of 3 randomized clinical trials evaluates patterns in antifungal resistance in patients in South India.

Invited Commentary

Real-time Augmented Reality—The Next Frontier for Ophthalmic Surgery

Abstract Full Text
JAMA Ophthalmol. Published online January 13, 2022. doi:10.1001/jamaophthalmol.2021.5745
Review

Challenges in Elucidating Ophthalmology’s Standards of Care: A Review

Abstract Full Text
JAMA Ophthalmol. Published online January 13, 2022. doi:10.1001/jamaophthalmol.2021.5511

This narrative review addresses challenges and topics related to the development and adoption of standards of care within ophthalmology.

JAMA Ophthalmology Clinical Challenge

Bilateral Hemorrhagic Optic Disc Edema in a Middle-aged Man

Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online January 13, 2022. doi:10.1001/jamaophthalmol.2021.3419

A 49-year-old man with a history of diabetes, hypertension, intravenous drug abuse, and multiple sexual partners presented with painless vision loss in both eyes for 10 days, left eye worse than right eye, and photophobia in both eyes. What would you do next?

January 6, 2022
Original Investigation

Visual Outcomes Associated With Patterns of Macular Edema Resolution in Central Retinal Vein Occlusion Treated With Anti–Vascular Endothelial Growth Factor Therapy: A Post Hoc Analysis of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) Trial

Abstract Full Text
JAMA Ophthalmol. Published online January 6, 2022. doi:10.1001/jamaophthalmol.2021.5619

This post hoc analysis of the LEAVO Trial assesses best-corrected visual acuity outcomes at 100 weeks based on macular fluid resolution patterns by 52 and 100 weeks among patients receiving anti–vascular endothelial growth factor therapy for central retinal vein occlusion–related macular edema.

Incidence and Progression of Myopia in Early Adulthood

Abstract Full Text
has audio
JAMA Ophthalmol. Published online January 6, 2022. doi:10.1001/jamaophthalmol.2021.5067

This cohort study investigates the 8-year incidence of myopia and change in ocular biometry in young adults and their association with the known risk factors for childhood myopia.

Invited Commentary

Central Retinal Vein Occlusion—What Is the Potential Importance of Persistent and Recurrent Macular Edema?

Abstract Full Text
JAMA Ophthalmol. Published online January 6, 2022. doi:10.1001/jamaophthalmol.2021.5620
JAMA Ophthalmology Clinical Challenge

Macular Fluid in a Patient With a Reported History of Normal-Tension Glaucoma

Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online January 6, 2022. doi:10.1001/jamaophthalmol.2021.3326

A patient with a history of normal-tension glaucoma and 5 years of latanoprost treatment for an enlarged cup-disc ratio presented with a blurred spot in the central vision of the right eye. What would you do next?

×